These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37457471)

  • 1. Exploring the 5-Substituted 2-Aminobenzothiazole-Based DNA Gyrase B Inhibitors Active against ESKAPE Pathogens.
    Sterle M; Durcik M; Stevenson CEM; Henderson SR; Szili PE; Czikkely M; Lawson DM; Maxwell A; Cahard D; Kikelj D; Zidar N; Pal C; Mašič LP; Ilaš J; Tomašič T; Cotman AE; Zega A
    ACS Omega; 2023 Jul; 8(27):24387-24395. PubMed ID: 37457471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New
    Cotman AE; Fulgheri F; Piga M; Peršolja P; Tiz DB; Skok Ž; Durcik M; Sterle M; Dernovšek J; Cruz CD; Tammela P; Szili PÉ; Daruka L; Pál C; Zega A; Mašič LP; Ilaš J; Tomašič T; Kikelj D; Zidar N
    RSC Adv; 2024 Sep; 14(39):28423-28454. PubMed ID: 39247510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel 1,2,4-oxadiazole-chalcone/oxime hybrids as potential antibacterial DNA gyrase inhibitors: Design, synthesis, ADMET prediction and molecular docking study.
    Ibrahim TS; Almalki AJ; Moustafa AH; Allam RM; Abuo-Rahma GEA; El Subbagh HI; Mohamed MFA
    Bioorg Chem; 2021 Jun; 111():104885. PubMed ID: 33838559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and Hit-to-Lead Optimization of Benzothiazole Scaffold-Based DNA Gyrase Inhibitors with Potent Activity against
    Cotman AE; Durcik M; Benedetto Tiz D; Fulgheri F; Secci D; Sterle M; Možina Š; Skok Ž; Zidar N; Zega A; Ilaš J; Peterlin Mašič L; Tomašič T; Hughes D; Huseby DL; Cao S; Garoff L; Berruga Fernández T; Giachou P; Crone L; Simoff I; Svensson R; Birnir B; Korol SV; Jin Z; Vicente F; Ramos MC; de la Cruz M; Glinghammar B; Lenhammar L; Henderson SR; Mundy JEA; Maxwell A; Stevenson CEM; Lawson DM; Janssen GV; Sterk GJ; Kikelj D
    J Med Chem; 2023 Jan; 66(2):1380-1425. PubMed ID: 36634346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New dual ATP-competitive inhibitors of bacterial DNA gyrase and topoisomerase IV active against ESKAPE pathogens.
    Durcik M; Nyerges Á; Skok Ž; Skledar DG; Trontelj J; Zidar N; Ilaš J; Zega A; Cruz CD; Tammela P; Welin M; Kimbung YR; Focht D; Benek O; Révész T; Draskovits G; Szili PÉ; Daruka L; Pál C; Kikelj D; Mašič LP; Tomašič T
    Eur J Med Chem; 2021 Mar; 213():113200. PubMed ID: 33524686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the Chemical Space of Benzothiazole-Based DNA Gyrase B Inhibitors.
    Skok Ž; Barančoková M; Benek O; Cruz CD; Tammela P; Tomašič T; Zidar N; Mašič LP; Zega A; Stevenson CEM; Mundy JEA; Lawson DM; Maxwell A; Kikelj D; Ilaš J
    ACS Med Chem Lett; 2020 Dec; 11(12):2433-2440. PubMed ID: 33329764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel 2-arylbenzothiazole DNA gyrase inhibitors: Synthesis, antimicrobial evaluation, QSAR and molecular docking studies.
    Ghannam IAY; Abd El-Meguid EA; Ali IH; Sheir DH; El Kerdawy AM
    Bioorg Chem; 2019 Dec; 93():103373. PubMed ID: 31698294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Norfloxacin salts of carboxylic acids curtail planktonic and biofilm mode of growth in ESKAPE pathogens.
    Lowrence RC; Ramakrishnan A; Sundaramoorthy NS; Shyam A; Mohan V; Subbarao HMV; Ulaganathan V; Raman T; Solomon A; Nagarajan S
    J Appl Microbiol; 2018 Feb; 124(2):408-422. PubMed ID: 29178633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental and Molecular Docking Studies of Cyclic Diphenyl Phosphonates as DNA Gyrase Inhibitors for Fluoroquinolone-Resistant Pathogens.
    Saleh NM; Moemen YS; Mohamed SH; Fathy G; Ahmed AAS; Al-Ghamdi AA; Ullah S; El Sayed IE
    Antibiotics (Basel); 2022 Jan; 11(1):. PubMed ID: 35052930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular docking, discovery, synthesis, and pharmacological properties of new 6-substituted-2-(3-phenoxyphenyl)-4-phenyl quinoline derivatives; an approach to developing potent DNA gyrase inhibitors/antibacterial agents.
    Alagumuthu M; Arumugam S
    Bioorg Med Chem; 2017 Feb; 25(4):1448-1455. PubMed ID: 28094220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of ciprofloxacin-linked 1,2,3-triazole conjugates as potent antibacterial agents using click chemistry: exploring their function as DNA gyrase inhibitors
    Patel UK; Tiwari P; Tilak R; Joshi G; Kumar R; Agarwal A
    RSC Adv; 2024 May; 14(24):17051-17070. PubMed ID: 38818013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational Approaches to Develop Isoquinoline Based Antibiotics through DNA Gyrase Inhibition Mechanisms Unveiled through Antibacterial Evaluation and Molecular Docking.
    Alagumuthu M; Muralidharan VP; Andrew M; Ahmed MH; Iyer SK; Arumugam S
    Mol Inform; 2018 Dec; 37(12):e1800048. PubMed ID: 30051592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, antimicrobial evaluation, DNA gyrase inhibition, and in silico pharmacokinetic studies of novel quinoline derivatives.
    El-Shershaby MH; El-Gamal KM; Bayoumi AH; El-Adl K; Ahmed HEA; Abulkhair HS
    Arch Pharm (Weinheim); 2021 Feb; 354(2):e2000277. PubMed ID: 33078877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzothiazole Clubbed Imidazolone Derivatives: Synthesis, Molecular Docking, DFT Studies, and Antimicrobial Studies.
    Desai N; Maheta A; Jethawa A; Ahmad I; Patel H; Dave B
    Curr Comput Aided Drug Des; 2023; 19(2):123-136. PubMed ID: 36411562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, and antibacterial activity of novel 4,5-dihydro-1H-pyrazole derivatives as DNA gyrase inhibitors.
    Liu JJ; Sun J; Fang YB; Yang YA; Jiao RH; Zhu HL
    Org Biomol Chem; 2014 Feb; 12(6):998-1008. PubMed ID: 24382549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, Molecular Docking, and Antimicrobial Evaluation of 2-(Substituted Amino)-N-(6-Substituted-1,3-Benzothiazol-2yl) Acetamide.
    Pawar S; Kale A; Zori P; Zope D
    Curr Drug Discov Technol; 2024 Jun; ():. PubMed ID: 38910468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Differences between E. coli and ESKAPE Pathogen GroES/GroEL.
    Sivinski J; Ambrose AJ; Panfilenko I; Zerio CJ; Machulis JM; Mollasalehi N; Kaneko LK; Stevens M; Ray AM; Park Y; Wu C; Hoang QQ; Johnson SM; Chapman E
    mBio; 2021 Jan; 12(1):. PubMed ID: 33436430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescence High-Throughput Screening for Inhibitors of TonB Action.
    Nairn BL; Eliasson OS; Hyder DR; Long NJ; Majumdar A; Chakravorty S; McDonald P; Roy A; Newton SM; Klebba PE
    J Bacteriol; 2017 May; 199(10):. PubMed ID: 28242720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, Antimicrobial Activity and Molecular Docking of Novel Thiourea Derivatives Tagged with Thiadiazole, Imidazole and Triazine Moieties as Potential DNA Gyrase and Topoisomerase IV Inhibitors.
    Hashem HE; Amr AEE; Nossier ES; Elsayed EA; Azmy EM
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32549386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and Evaluation of N-Phenylpyrrolamides as DNA Gyrase B Inhibitors.
    Durcik M; Tammela P; Barančoková M; Tomašič T; Ilaš J; Kikelj D; Zidar N
    ChemMedChem; 2018 Jan; 13(2):186-198. PubMed ID: 29206345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.